Right2Try Inc. – Trademark Portfolio

Entity Type: 03

Right2Try Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include DOXYMED, IVERMED, ALBENMED, MEBENMED, and PRAZIMED. The owner is based in Lewes, DE.

16192 Coastal Hwy.

Lewes, DE 19958

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Right2Try Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Right2Try Inc. have?

Right2Try Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.

What trademark classes does Right2Try Inc. file in?

Right2Try Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Right2Try Inc.'s most well-known trademarks?

Right2Try Inc.'s registered trademark portfolio includes well-known marks such as DOXYMED, IVERMED, ALBENMED, MEBENMED, and PRAZIMED. These are among 7 currently registered trademarks in the portfolio.

What is Right2Try Inc.'s trademark registration success rate?

Right2Try Inc. has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.